INSTITUT JEROME LEJEUNE - France 

Ranking results:

Past rankings:

2020
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:> 1000
Total Number of Projects:> 1000

Ranking timeline:

Project Participation Performance(2020-01-01 - 2024-12-31 ):

Total Project Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:

Leadership:

Total number of projects: 2
As coordinator: 0
As participant: 2
Sole participant: 0
Coordinator / Participant Ratio: 0*

*Ratio includes only projects with > 2 partners

Summary:

Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2021 0 5.989.840 287.500 1
2020 0 5.965.968 344.044 1
*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:

Institution:Projects [No]:
AELIS FARMA1
ASSOCIAZIONE OASI MARIA SS ONLUS1
CENTRE DE REGULACIO GENOMICA1
CENTRE EUROPEEN DE RECHERCHE EN BIOLOGIE ET EN MEDECINE1
CENTRE HOSPITALIER UNIVERSITAIRE DE SAINT ETIENNE1
CONCENTRIS RESEARCH MANAGEMENT1
CONSORCIO MAR PARC DE SALUT DE BARCELONA1
FUNDACIO IMIM1
FUNDACION PARA LA INVESTIGACION BIOMEDICA DEL HOSPITAL UNIVERSITARIO LA PRINCESA1
GSF FORSCHUNGSZENTRUM FUER UMWELT UND GESUNDHEIT1
INSTITUT DU CERVEAU ET DE LA MOELLE EPINIERE1
KING'S COLLEGE LONDON1
PERHA PHARMACEUTICALS SAS1
QUEEN MARY AND WESTFIELD COLLEGE UNIVERSITY OF LONDON1
SERVICIO MADRILENO DE SALUD1
TRISOMY 21 RESEARCH SOCIETY1
UNIVERSITY OF CAMBRIDGE1

Constancy:

Total number of partners: 17
Partner loyalty:
Frequent Partner: (> 2 projects): 0
Rare Partner: 17
Frequent / Rare Partner Ratio: 0

Project overview:

Start dateProjectacronymrolefundingpartners
2021-02-01Improving COgnition in Down syndrome ICODparticipant5.989.8407
2020-01-01Gene overdosage and comorbidities during the early lifetime in Down Syndrome GO-DS21participant5.965.96812